Generic Drugs Market Opportunity Assessment for the Period of 2016 to 2021 with SWOT Analysis of Key Industry Players
Generic drugs are copies of branded drugs that have same composition, effects, risks, and functions as the original drug but at a lower price and usually subject to government regulations in the countries where they are dispensed. Generic drugs are also known as abbreviated drugs. To sell a generic drug manufacturing company must submit an Abbreviated New Drug Application for approval. The Drug Price Competition and Patent Term Restoration Act of 1984, mostly known as the Hatch-Waxman Act, made ANDAs...
View full press release